Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 2
2016 5
2017 7
2018 4
2019 3
2020 4
2021 1
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
Guerra I, Barros F, Chaparro M, Benítez JM, Martín-Arranz MD, de Francisco R, Piqueras M, de Castro L, Carbajo AY, Bermejo F, Mínguez M, Gutiérrez A, Mesonero F, Cañete F, González-Muñoza C, Calvo M, Sicilia B, Alfambra E, Rivero M, Lucendo AJ, Tardillo CA, Almela P, Bujanda L, van Domselaar M, Ramos L, Fernández Sánchez M, Hinojosa E, Verdejo C, Gimenez A, Rodríguez-Lago I, Manceñido N, Pérez Calle JL, Moreno MDP, Delgado-Guillena PG, Antolín B, Ramírez de la Piscina P, Casanova MJ, Soto Escribano P, Martín Arranz E, Pérez-Martínez I, Mena R, García Morales N, Granja A, Boscá Watts MM, Francés R, Fernández C, Calafat M, Roig-Ramos C, Vera MI, Carracedo Á, Domènech E, Gisbert JP; ENEIDA Project of GETECCU. Guerra I, et al. Among authors: bosca watts mm. Dig Dis. 2024 Mar 7. doi: 10.1159/000537782. Online ahead of print. Dig Dis. 2024. PMID: 38452742
Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial.
Loras C, Ruiz-Ramirez P, Romero J, Andújar X, Bargallo J, Bernardos E, Boscá-Watts MM, Brugiotti C, Brunet E, Busquets D, Cerrillo E, Cortina FJ, Díaz-Milanés JA, Dueñas C, Farrés R, Golda T, González-Huix F, Gornals JB, Guardiola J, Julià D, Lira A, Llaó J, Mañosa M, Marin I, Millán M, Monfort D, Moro D, Mullerat J, Navarro M, Pérez Roldán F, Pijoan E, Pons V, Reyes J, Rufas M, Sainz E, Sanchiz V, Serracant A, Sese E, Soto C, Troya J, Zaragoza N, Tebé C, Paraira M, Sudrià-Lopez E, Mayor V, Fernández-Bañares F, Esteve M; Grupo Español de Trabajo de la Enfermedad de Crohn y Colitis Ulcerosa GETECCU. Loras C, et al. Among authors: bosca watts mm. Trials. 2023 Jun 27;24(1):432. doi: 10.1186/s13063-023-07447-1. Trials. 2023. PMID: 37365665 Free PMC article. Clinical Trial.
Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors.
Davis González MR, Ballester MP, Romero-González E, Sánchez-Pardo AM, Marti-Aguado D, Tosca J, Suria C, Antón Ausejo R, Pascual Moreno I, Planelles Silvestre MD, Mínguez Pérez M, Bosca-Watts MM. Davis González MR, et al. Among authors: bosca watts mm. Gastroenterol Hepatol. 2023 Nov;46(9):671-681. doi: 10.1016/j.gastrohep.2022.10.021. Epub 2022 Nov 11. Gastroenterol Hepatol. 2023. PMID: 36375696 English, Spanish.
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
Chaparro M, Baston-Rey I, Fernández Salgado E, González García J, Ramos L, Diz-Lois Palomares MT, Argüelles-Arias F, Iglesias Flores E, Cabello M, Rubio Iturria S, Núñez Ortiz A, Charro M, Ginard D, Dueñas Sadornil C, Merino Ochoa O, Busquets D, Iyo E, Gutiérrez Casbas A, Ramírez de la Piscina P, Boscá-Watts MM, Arroyo M, García MJ, Hinojosa E, Gordillo J, Martínez Montiel P, Velayos Jiménez B, Quílez Ivorra C, Vázquez Morón JM, Huguet JM, González-Lama Y, Muñagorri Santos AI, Amo VM, Martín Arranz MD, Bermejo F, Martínez Cadilla J, Rubín de Célix C, Fradejas Salazar P, López San Román A, Jiménez N, García-López S, Figuerola A, Jiménez I, Martínez Cerezo FJ, Taxonera C, Varela P, de Francisco R, Monfort D, Molina Arriero G, Hernández-Camba A, García Alonso FJ, Van Domselaar M, Pajares-Villarroya R, Núñez A, Rodríguez Moranta F, Marín-Jiménez I, Robles Alonso V, Martín Rodríguez MDM, Camo-Monterde P, García Tercero I, Navarro-Llavat M, García LA, Hervías Cruz D, Kloss S, Passey A, Novella C, Vispo E, Barreiro-de Acosta M, Gisbert JP. Chaparro M, et al. Among authors: bosca watts mm. J Clin Med. 2022 Aug 3;11(15):4518. doi: 10.3390/jcm11154518. J Clin Med. 2022. PMID: 35956133 Free PMC article.
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Chaparro M, Baston-Rey I, Fernández-Salgado E, González García J, Ramos L, Diz-Lois Palomares MT, Argüelles-Arias F, Iglesias Flores E, Cabello M, Rubio Iturria S, Núñez Ortiz A, Charro M, Ginard D, Dueñas Sadornil C, Merino Ochoa O, Busquets D, Iyo E, Gutiérrez Casbas A, Ramírez de la Piscina P, Boscá-Watts MM, Arroyo M, García MJ, Hinojosa E, Gordillo J, Martínez Montiel P, Velayos Jiménez B, Quílez Ivorra C, Vázquez Morón JM, María Huguet J, González-Lama Y, Muñagorri Santos AI, Amo VM, Martín-Arranz MD, Bermejo F, Martínez Cadilla J, Rubín de Célix C, Fradejas Salazar P, San Román AL, Jiménez N, García López S, Figuerola A, Jiménez I, Martínez Cerezo FJ, Taxonera C, Varela P, de Francisco R, Monfort D, Molina Arriero G, Hernández Camba A, García-Alonso FJ, Van Domselaar M, Pajares Villarroya R, Núñez A, Rodríguez Moranta F, Marín-Jiménez I, Robles Alonso V, Martín Rodríguez MDM, Camo-Monterde P, García Tercero I, Navarro Llavat M, Arias García L, Hervías Cruz D, Sulleiro S, Novella C, Vispo E, Barreiro-de Acosta M, Gisbert JP. Chaparro M, et al. Among authors: bosca watts mm. Inflamm Bowel Dis. 2022 Nov 2;28(11):1725-1736. doi: 10.1093/ibd/izab357. Inflamm Bowel Dis. 2022. PMID: 35166347 Free PMC article.
Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial.
Loras C, Andújar X, Gornals JB, Sanchiz V, Brullet E, Sicilia B, Martín-Arranz MD, Naranjo A, Barrio J, Dueñas C, Foruny JR, Busquets D, Monfort D, Pineda JR, González-Huix F, Pérez-Roldán F, Pons V, González B, Reyes Moreno J, Sainz E, Guardiola J, Bosca-Watts MM, Fernández-Bañares F, Mayor V, Esteve M; Grupo Español de Trabajo de la Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Loras C, et al. Among authors: bosca watts mm. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):332-341. doi: 10.1016/S2468-1253(21)00386-1. Epub 2022 Jan 20. Lancet Gastroenterol Hepatol. 2022. PMID: 35065738 Clinical Trial.
Thiopurine adherence: a high prevalence with low impact on UC outcomes.
Gómez-Medina C, Capilla-Lozano M, Ballester-Ferré MP, Martí-Aguado D, Crespo A, Bosca-Watts MM, Navarro-Cortés P, Antón R, Pascual-Moreno I, Tosca Cuquerella J, Mínguez Pérez M. Gómez-Medina C, et al. Among authors: bosca watts mm. Rev Esp Enferm Dig. 2022 Feb;114(2):76-82. doi: 10.17235/reed.2021.7630/2020. Rev Esp Enferm Dig. 2022. PMID: 33733802 Free article.
33 results